IMPDH1
IMPDH1 (inosine-5'-monophosphate dehydrogenase 1) is an enzyme that catalyses the first committed, rate-limiting step in the de novo synthesis of guanine nucleotides. It is also known as sWSS2608, LCA11 and RP10, and is linked to retinitis pigmentosa type 10. Browse Assay Genie's current range of IMPDH1 research reagents below, or read on for the biology behind the target.
IMPDH1 catalyses the conversion of inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP). This is the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, so the enzyme plays an important role in the regulation of cell growth. The protein acts as a homotetramer. UniProt also notes that it could have single-stranded nucleic acid-binding activity and might play a role in RNA and/or DNA metabolism, and that it may contribute to the development of malignancy and the growth progression of some tumours.
The IMPDH1 gene encodes a protein that belongs to the IMPDH/GMPR family, grouped by HGNC as the inosine monophosphate dehydrogenase family. The protein localises to the cytoplasm and the nucleus. Several transcript variants encoding different isoforms have been reported for the gene. Researchers working on purine metabolism often study IMPDH1 alongside its paralogue IMPDH2, and the mouse and rat orthologs are both named Impdh1.
The gene has carried several names. Previous names include retinitis pigmentosa 10 (autosomal dominant) and IMP (inosine 5'-monophosphate) dehydrogenase 1, and the aliases sWSS2608, LCA11 and RP10 appear in the literature. These reflect the disease association: defects in this gene are a cause of retinitis pigmentosa type 10 (RP10). That link makes the IMPDH1 gene relevant to retinal biology as well as to nucleotide metabolism, and it is a common subject for work using an IMPDH1 antibody, IMPDH1 ELISA kit or recombinant IMPDH1 protein.
IMPDH1 catalyses the rate-limiting step of de novo guanine nucleotide synthesis, making it a central enzyme for studying purine biosynthesis.
By controlling guanine nucleotide supply, IMPDH1 plays an important role in the regulation of cell growth.
Defects in IMPDH1 cause retinitis pigmentosa type 10, so the gene is studied in inherited retinal disease.
UniProt notes a possible role for IMPDH1 in the development of malignancy and the growth progression of some tumours.
IMPDH1 converts inosine 5'-phosphate (IMP) to xanthosine 5'-phosphate (XMP). This is the first committed and rate-limiting step in the de novo synthesis of guanine nucleotides, which is why the enzyme helps regulate cell growth. It acts as a homotetramer.
IMPDH1 is also called sWSS2608, LCA11 and RP10, and was previously named IMP (inosine 5'-monophosphate) dehydrogenase 1 and retinitis pigmentosa 10 (autosomal dominant). Several transcript variants encoding different isoforms have been described for the gene.
Defects in IMPDH1 are a cause of retinitis pigmentosa type 10 (RP10). UniProt also suggests a possible role in malignancy and tumour growth progression. Mouse and rat both have an ortholog named Impdh1; check the datasheet of any product for its validated reactivity.
Other IMP dehydrogenase family members and purine-metabolism targets with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P20839; product specifications from Assay Genie datasheets.